Jupiter Life Line [JLHL] vs Wockhardt [WOCKPHARMA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Jupiter Life Line Hospitals Limited wins in 16 metrics, Wockhardt Ltd. wins in 3 metrics, with 0 ties. Jupiter Life Line Hospitals Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Jupiter Life Line Hospitals Limited | Wockhardt Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 43.84 | 1,141.97 | Jupiter Life Line Hospitals Limited |
| Price-to-Book Ratio | 5.71 | 5.15 | Wockhardt Ltd. |
| Debt-to-Equity Ratio | 27.81 | 50.37 | Jupiter Life Line Hospitals Limited |
| PEG Ratio | -1.39 | -3.30 | Jupiter Life Line Hospitals Limited |
| EV/EBITDA | 26.83 | 53.38 | Jupiter Life Line Hospitals Limited |
| Profit Margin (TTM) | 13.45% | 0.69% | Jupiter Life Line Hospitals Limited |
| Operating Margin (TTM) | 16.89% | 12.16% | Jupiter Life Line Hospitals Limited |
| EBITDA Margin (TTM) | 16.89% | 12.16% | Jupiter Life Line Hospitals Limited |
| Return on Equity | 14.27% | -1.01% | Jupiter Life Line Hospitals Limited |
| Return on Assets (TTM) | 10.16% | -0.58% | Jupiter Life Line Hospitals Limited |
| Free Cash Flow (TTM) | $-674.22M | $-3.87B | Jupiter Life Line Hospitals Limited |
| Dividend Yield | 0.13% | N/A | N/A |
| 1-Year Return | -13.68% | 9.11% | Wockhardt Ltd. |
| Price-to-Sales Ratio (TTM) | 5.88 | 7.42 | Jupiter Life Line Hospitals Limited |
| Enterprise Value | $83.21B | $247.94B | Wockhardt Ltd. |
| EV/Revenue Ratio | 5.91 | 7.81 | Jupiter Life Line Hospitals Limited |
| Gross Profit Margin (TTM) | 81.10% | 64.30% | Jupiter Life Line Hospitals Limited |
| Revenue per Share (TTM) | $215 | $196 | Jupiter Life Line Hospitals Limited |
| Earnings per Share (Diluted) | $28.82 | $1.27 | Jupiter Life Line Hospitals Limited |
| Beta (Stock Volatility) | 0.32 | 0.75 | Jupiter Life Line Hospitals Limited |
Jupiter Life Line Hospitals Limited vs Wockhardt Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Jupiter Life Line Hospitals Limited | 0.71% | -0.62% | -0.11% | 4.17% | -6.04% | -5.21% |
| Wockhardt Ltd. | -1.57% | 0.78% | 23.40% | 59.45% | 42.25% | 34.06% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Jupiter Life Line Hospitals Limited | -13.68% | 23.68% | 23.68% | 23.68% | 23.68% | 23.68% |
| Wockhardt Ltd. | 9.11% | 800.56% | 255.99% | 137.73% | 466.67% | 500.32% |
Performance & Financial Health Analysis: Jupiter Life Line Hospitals Limited vs Wockhardt Ltd.
| Metric | JLHL | WOCKPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹82.82B | ₹228.33B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 10,379 | 642,256 |
| 90 Day Avg. Volume | 26,174 | 678,723 |
| Last Close | ₹1,325.00 | ₹1,907.60 |
| 52 Week Range | ₹1,178.00 - ₹1,625.00 | ₹1,086.70 - ₹2,422.30 |
| % from 52W High | -18.46% | -21.25% |
| All-Time High | ₹1,770.00 (Mar 24, 2025) | ₹2,422.30 (Jun 01, 2026) |
| % from All-Time High | -25.14% | -21.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.23% |
| Quarterly Earnings Growth | -0.19% | 3.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.01% |
| Operating Margin (TTM) | 0.17% | 0.12% |
| Return on Equity (TTM) | 0.14% | -0.01% |
| Debt to Equity (MRQ) | 27.81 | 50.37 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹221.36 | ₹281.63 |
| Cash per Share (MRQ) | ₹84.76 | ₹59.84 |
| Operating Cash Flow (TTM) | ₹2.61B | ₹-2,910,000,000 |
| Levered Free Cash Flow (TTM) | ₹1.94B | ₹-470,000,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.13% | N/A |
| Last 12-Month Dividend | ₹2.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Jupiter Life Line Hospitals Limited vs Wockhardt Ltd.
| Metric | JLHL (Apr 24, 2026) | WOCKPHARMA (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 43.84 | 1,141.97 |
| Forward P/E | 38.52 | N/A |
| PEG Ratio | -1.39 | -3.30 |
| Price to Sales (TTM) | 5.88 | 7.42 |
| Price to Book (MRQ) | 5.71 | 5.15 |
| Market Capitalization | ||
| Market Capitalization | ₹82.82B | ₹228.33B |
| Enterprise Value | ₹83.21B | ₹247.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.91 | 7.81 |
| Enterprise to EBITDA | 26.83 | 53.38 |
| Risk & Other Metrics | ||
| Beta | 0.32 | 0.75 |
| Book Value per Share (MRQ) | ₹221.36 | ₹281.63 |
Financial Statements Comparison: Jupiter Life Line Hospitals Limited vs Wockhardt Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | JLHL (2025) | WOCKPHARMA (2025) |
|---|---|---|
| Revenue/Sales | 12.56B | 29.15B |
| Cost of Goods Sold | 2.59B | 11.32B |
| COGS % of Revenue | 20.7% | 38.8% |
| Gross Profit | 9.96B | 17.83B |
| Gross Margin | 79.3% | 61.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 2.42B | 1.80B |
| Operating Margin | 19.3% | 6.2% |
| EBITDA | 3.14B | 4.51B |
| EBITDA Margin | 25.0% | 15.5% |
| Pre-Tax Income | 2.58B | -160.00M |
| Pre-Tax Income % of Revenue | 20.5% | -0.5% |
| Income Tax | 642.01M | 410.00M |
| Income Tax % of Revenue | 5.1% | 1.4% |
| Net Income (Profit) | 1.94B | -570.00M |
| Profit Margin | 15.4% | -2.0% |
Balance Sheet & Liquidity Metrics
| Metric | JLHL (2025) | WOCKPHARMA (2025) |
|---|---|---|
| Cash & Equivalents | 3.68B | 1.12B |
| Total Current Assets | 6.87B | 25.69B |
| Total Current Assets % of Revenue | 54.7% | 88.1% |
| Total Current Liabilities | 1.52B | 20.42B |
| Total Current Liabilities % of Revenue | 12.1% | 70.1% |
| Long-Term Debt | 3.84B | 13.06B |
| Long-Term Debt % of Revenue | 30.6% | 44.8% |
| Total Shareholders Equity | 13.56B | 46.57B |
| Retained Earnings | 5.52B | 1.88B |
| Retained Earnings % of Revenue | 44.0% | 6.4% |
| Property, Plant & Equipment | 3.64B | 970.00M |
Cash Flow Statement Comparison
| Metric | JLHL (2025) | WOCKPHARMA (2025) |
|---|---|---|
| Operating Cash Flow | 2.61B | -2.91B |
| Operating Cash Flow % of Revenue | 20.8% | -10.0% |
| Capital Expenditures | -3.20B | -840.00M |
| Free Cash Flow | -674.22M | -3.87B |
| FCF Margin | -5.4% | -13.3% |
| Debt Repayment | N/A | -10.67B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | JLHL | WOCKPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 65.57M | 162.49M |
| Float Shares | 23.76M | 76.93M |
| % Held by Insiders | 66.73% | 51.02% |
| % Held by Institutions | 20.90% | 15.03% |
| % Held by Public | 12.37% | 33.95% |
Dividend Analysis & Yield Comparison: Jupiter Life Line Hospitals Limited vs Wockhardt Ltd.
| Metric | JLHL | WOCKPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.13% | N/A |
| 3-Year Avg Annual Dividend | ₹0.67 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.08% | N/A |
| 3-Year Total Dividends | ₹2.00 | ₹0.00 |
| Ex-Dividend Date | Jul 04, 2025 | N/A |